MiNK Therapeutics, Inc.
NASDAQ:INKT · NASDAQ Capital Market
-$0.32 today
Vol 0.02M · Avg 0.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+60.88%
Period High
$64.17
Period Low
$6.98
Latest
$12.05
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Equillium, Inc.
NASDAQ:EQ
$99.82M
vTv Therapeutics Inc.
NASDAQ:VTVT
$85.75M
OS Therapies Incorporated
AMEX:OSTX
$75.71M
Gain Therapeutics, Inc.
NASDAQ:GANX
$71.66M
Spruce Biosciences, Inc.
NASDAQ:SPRB
$71.19M
NRx Pharmaceuticals, Inc.
NASDAQ:NRXP
$66.38M
Outlook Therapeutics, Inc.
NASDAQ:OTLK
$50.19M
CervoMed Inc.
CRVO
$22.68M
Werewolf Therapeutics, Inc.
HOWL
$18.52M
IO Biotech, Inc.
IOBT
$885,690.00
What is the latest INKT filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does INKT have?
Intrinsic Alpha currently shows 20 recent filings for INKT.
Explore More
Continue the stock analysis
Jump to another research area for this company.